Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-04

Clinical Trial Update: Intrathecal Fentanyl and Dexmedetomidine Added to Bupivacaine for Subarachnoid Anaesthesia for Percutaneous Nephrolithotomy [NA]

View source ↗

Summary

The study evaluates adding intrathecal fentanyl and dexmedetomidine to bupivacaine for subarachnoid anesthesia in percutaneous nephrolithotomy. The trial is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)
  • Dexmedetomidine (Dexmedetomidine)
  • FENTANYL (FENTANYL)

Snippet

Sponsor: Alexandria University | Conditions: Percutaneous Nephrolithotomy (PCNL) | NA | Status: ACTIVE_NOT_RECRUITING